The page lists 26 projects related to the topic "oncogene".
# | |||
---|---|---|---|
1 | SUMOblock | Blocking SUMO conjugation as drug discovery strategy. | 2015 |
2 | DDRNA | DDRNA-based cancer therapy targeted telomeres | 2015 |
3 | DENOVOSTEM | DE NOVO GENERATION OF SOMATIC STEM CELLS: REGULATION AND MECHANISMS OF CELL PLASTICITY | 2015 |
4 | ALKATRAS | ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer | 2015 |
5 | SLACC | Supplying lung adenocarcinoma cell lines to the cancer research community. | 2015 |
6 | PEPTO1 | Feasibility study of a novel treatment for cancer based on a recombinant peptide therapy | 2016 |
7 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
8 | MPSC | Membrane Potential and Stem Cell Potency in Normal and Malignant Tissues | 2016 |
9 | GBM-CPP | Developing an anti-Myc cell-penetrating peptide for cancer treatment | 2016 |
10 | TKI resistance | Resistance mechanisms to tyrosine kinase inhibitors in solid tumors | 2016 |
11 | CancerFluxome | Cancer Cellular Metabolism across Space and Time | 2017 |
12 | RepliStressTiming | Impact of replicative stress on DNA replication timing control | 2017 |
13 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
14 | ONCOGENEVOL | The evolutionary history of oncogenic and non-oncogenic papillomaviruses | 2017 |
15 | iAML-lncTARGET | Targeting the transcriptional landscape in infant AML | 2017 |
16 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
17 | INSITUMUT | Direct detection of cancer-causing mutations in tumour specimens | 2018 |
18 | MechDeath | Study of the mechanical cues driving cell competition and its role in pretumoral cell expansion | 2019 |
19 | TALVIN | Inhibiting mechanotransduction for the treatment of pancreatic cancer | 2018 |
20 | REPLISTRESS | DNA Replication: From Physiology to Replication Stress in Human Cancer | 2018 |
21 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
22 | EPICAN | Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer | 2020 |
23 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
24 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
25 | NUCDDR | Nucleolar Responses to DNA Damage: rDNA, an emerging hub of genome instability | 2020 |
26 | RASATaC | Regulating RAS Activity to Target RAS-Driven Cancers | 2020 |